BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
103 hedge funds and large institutions have $273M invested in BioDelivery Sciences International, Inc. in 2019 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 40 increasing their positions, 20 reducing their positions, and 9 closing their positions.
200% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 9
117% more call options, than puts
Call options by funds: $967K | Put options by funds: $445K
100% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 20
78% more capital invested
Capital invested by funds: $153M → $273M (+$120M)
20% more funds holding
Funds holding: 86 → 103 (+17)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$12.3M |
| 2 |
Morgan Stanley
New York
|
+$7.86M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$7.11M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$6.35M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$11.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.55M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$3.7M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$2.55M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.67M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GWM
101
Geneos Wealth Management
Englewood,
Colorado
| $4K | – | – | – |
|
|
FIA
102
FNY Investment Advisers
New York
| $2K | – | – | – |
|
103
US Bancorp
Minneapolis,
Minnesota
| $1K | – | – | – |
|
|
104
Point72 Asset Management
Stamford,
Connecticut
| – | -$5.55M | -1,500,000 | Closed |
|
|
GTC
105
Ghost Tree Capital
New York
| – | -$3.7M | -1,000,000 | Closed |
|
|
FI
106
Fosun International
Hong Kong,
China
| – | -$834K | -286,645 | Closed |
|
|
WVP
107
Worth Venture Partners
Fort Lee,
New Jersey
| – | -$754K | -204,256 | Closed |
|
|
SC
108
Searle & Co
Greenwich,
Connecticut
| – | -$676K | -182,650 | Closed |
|
109
Parallax Volatility Advisers
San Francisco,
California
| – | -$200K | -54,170 | Closed |
|
|
FCMT
110
Founders Capital Management (Texas)
Houston,
Texas
| – | -$22K | -6,000 | Closed |
|
|
AIC
111
Ameritas Investment Company
Lincoln,
Nebraska
| – | -$11K | -2,900 | Closed |
|
|
IA
112
IFP Advisors
Tampa,
Florida
| – | -$8K | -2,500 | Closed |
|
BDSI Hedge Fund Activity: Q1 2019 in Review
103 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2019, worth a combined $273M — up 78% from $153M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new BDSI positions and 9 closed out — a net gain of 18 holders — while 40 added to existing stakes and 20 trimmed.
The largest buyer was Avoro Capital Advisors, adding an estimated $12.3M. The largest seller was Stonepine Capital Management, cutting an estimated $11.2M.
- 103 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2019, up from 86 in Q4 2018.
- Funds reported $273M of BioDelivery Sciences International, Inc. stock for Q1 2019, up 78% quarter-over-quarter.
- 27 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2019 and 9 closed out, a net change of +18 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q1 2019 was Avoro Capital Advisors, an estimated $12.3M added.
- The largest BioDelivery Sciences International, Inc. seller in Q1 2019 was Stonepine Capital Management, an estimated $11.2M sold.
Based on aggregated 13F filings for Q1 2019.